Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei
about
Melioidosis: epidemiology, pathophysiology, and management.Animal models for Francisella tularensis and Burkholderia species: scientific and regulatory gaps toward approval of antibiotics under the FDA Animal RuleCharacterization of the Burkholderia mallei tonB Mutant and Its Potential as a Backbone Strain for Vaccine DevelopmentThe innate interferon gamma response of BALB/c and C57BL/6 mice to in vitro Burkholderia pseudomallei infection.MyD88 dependent signaling contributes to protective host defense against Burkholderia pseudomalleiDifferential intracellular fate of Burkholderia pseudomallei 844 and Burkholderia thailandensis UE5 in human monocyte-derived dendritic cells and macrophages.The unexpected role for the aryl hydrocarbon receptor on susceptibility to experimental toxoplasmosisAdjuvant effects for oral immunization provided by recombinant Lactobacillus casei secreting biologically active murine interleukin-1{beta}Protection against experimental melioidosis following immunisation with a lipopolysaccharide-protein conjugate.Genome wide transcriptome profiling of a murine acute melioidosis model reveals new insights into how Burkholderia pseudomallei overcomes host innate immunityGenetic control of weight loss during pneumonic Burkholderia pseudomallei infection.Characterization of BPSS1521 (bprD), a regulator of Burkholderia pseudomallei virulence gene expression in the mouse model.Model of differential susceptibility to mucosal Burkholderia pseudomallei infection.CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c miceGlycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in miceAttenuation and persistence of and ability to induce protective immunity to a Staphylococcus aureus aroA mutant in mice.Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.Oropharyngeal aspiration of Burkholderia mallei and Burkholderia pseudomallei in BALB/c mice.Interrogation of the Burkholderia pseudomallei genome to address differential virulence among isolates.IL12Rβ1: the cytokine receptor that we used to know.Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice.Development of vaccines against burkholderia pseudomallei.Peri-implant tissue is an important niche for Staphylococcus epidermidis in experimental biomaterial-associated infection in mice.Characterization of the murine macrophage response to infection with virulent and avirulent Burkholderia species.Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidityB cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus.Natural history of inhalation melioidosis in rhesus macaques (Macaca mulatta) and African green monkeys (Chlorocebus aethiops).Molecular techniques in the diagnosis and management of infectious diseases: do they have a role in bacteriology?Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice.Comparison of tissue-selective proinflammatory gene induction in mice infected with wild-type, DNA adenine methylase-deficient, and flagellin-deficient Salmonella enterica.Host gene expression analysis in Sri Lankan melioidosis patients.Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.Impaired early cytokine responses at the site of infection in a murine model of type 2 diabetes and melioidosis comorbidity.Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells.Role for Toll-like receptor 2 in the immune response to Streptococcus pneumoniae infection in mouse otitis mediaDifferential Production of Type I IFN Determines the Reciprocal Levels of IL-10 and Proinflammatory Cytokines Produced by C57BL/6 and BALB/c Macrophages.Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis.The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease?Toll-like receptor 9 regulates tumor necrosis factor-alpha expression by different mechanisms. Implications for osteoclastogenesis.The art of persistence-the secrets to Burkholderia chronic infections.
P2860
Q24522461-DA28AB02-C575-4830-9948-BEC05B008EEAQ26859041-30888677-6CB6-413F-AC43-08F5DFE3262DQ27304432-56CB435E-74D9-41BE-A477-63478A81D03DQ33254463-51AB19D4-DF24-4660-A6BE-8CCEB81454E5Q33378896-3C3FA1FF-330A-42F5-8DE1-AFDF3D95AA88Q33435686-6334CACE-E732-4F97-A12F-4599A8EDE680Q33606707-C01CE75A-D3F1-4F95-B580-75F53B35C865Q33613453-982F67D4-5834-4DAD-B712-32827E9770A8Q33661479-7D3068EA-905A-48BF-806E-C29766A758D4Q33756790-07EDEE6D-E1CB-4A32-9F42-6589D52B7989Q33934354-97ED7BEF-DDEC-4E64-A456-9AD297BE58A1Q34027655-22AB17EE-A181-43D4-9711-A7946D3A545CQ34116653-D299D6E9-8B8C-4AE8-A313-1DB8FF9069EDQ34491695-9BEFC398-C307-4507-B7F3-9FF831830C80Q34552307-BEB91632-4B84-4E33-BBD6-39B87C572A1CQ34681033-3A50657A-322F-4C6F-9841-669987918B9CQ34681102-E598E3D6-51FC-403F-9782-B8C5A9C0F908Q34682080-417EE6C3-9902-4BF5-868D-4746AAFEB11AQ34764795-7B08A834-7055-4839-8BCA-0A6BE945036BQ35136546-DA117DB8-02F4-434D-9A0C-7970F0C44FFBQ35217529-321EBFF3-F508-43AD-9F55-92E36FADCA31Q35234118-0D9316A3-1073-4366-BA37-C46CFA58C3DDQ35689422-7A6534AD-8C28-48A0-8E4B-DFD53342E22DQ35834729-F7A1A8AB-B6AB-4AAB-B24D-874242B43488Q36018253-9DB512E6-F191-42DA-877E-B10C707828D4Q36091161-2010DFB1-0FF6-4404-BC9B-D3EF0D7F8EA9Q36163121-610DDA21-C333-4D42-A7E6-8262E97FAD27Q36231621-EAF156D0-854F-42EE-B820-98CAA576839EQ36289996-F4D2B4AA-77AC-4BB1-9644-C7A6AEDFECC1Q36314053-B4C377A3-C713-46AF-8C8C-D9CF53BE0E22Q36409109-4450D4CB-3EED-445C-91B2-8ED28AE1E960Q36445263-A9AFC197-C0E0-416A-84EF-6DD9B81CA50EQ36558710-98AE8A22-EC71-4FD8-AA93-B8415583637DQ37073972-EDBAB6B2-8DB9-43BE-A87B-A5B28B564143Q37256493-C7160AFE-3016-4FA2-93E8-3DA513246EEFQ37261539-BBCFAC4F-990A-4AD2-B771-CF08B217925CQ37451253-C929B304-6A7C-4B90-A975-778FF51711FBQ37592283-53351197-C980-47F0-8191-2F2C8EDF4CE4Q38335414-7BA00C57-CB45-402B-901F-229C3ADEFC2FQ38839466-2CE4D4E5-2001-49D7-979C-1543FF7AD351
P2860
Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cytokine gene expression in in ...... lent Burkholderia pseudomallei
@ast
Cytokine gene expression in in ...... lent Burkholderia pseudomallei
@en
Cytokine gene expression in in ...... lent Burkholderia pseudomallei
@nl
type
label
Cytokine gene expression in in ...... lent Burkholderia pseudomallei
@ast
Cytokine gene expression in in ...... lent Burkholderia pseudomallei
@en
Cytokine gene expression in in ...... lent Burkholderia pseudomallei
@nl
prefLabel
Cytokine gene expression in in ...... lent Burkholderia pseudomallei
@ast
Cytokine gene expression in in ...... lent Burkholderia pseudomallei
@en
Cytokine gene expression in in ...... lent Burkholderia pseudomallei
@nl
P2860
P1476
Cytokine gene expression in in ...... lent Burkholderia pseudomallei
@en
P2093
N Ketheesan
P2860
P304
P356
10.1128/IAI.68.4.2034-2042.2000
P407
P50
P577
2000-04-01T00:00:00Z